Introduction: Molluscum contagiosum is a viral infection of the skin that is spread from
INTRODUCTION
Molluscum contagiosum (MC) is a viral infection of the skin caused by a DNA poxvirus called the molluscum contagiosum virus. MC is spread from direct contact, either via person to person by touching affected lesions or innocuously via fomites. The skin infection is most common in children and sexually active adults. MC can affect any area of the skin, and remains infectious until the lesions have resolved. Most lesions will resolve without treatment, with the average length of infection lasting between 6 and 18 months [1] . The condition is often socially stigmatizing and patients subsequently seek treatment. Though there are many anecdotal remedies, none have been shown to be universally effective as a take-home prescription option in controlled clinical trials.
CASE REPORT
A 16-year-old girl presented with a 4-week history of an asymptomatic rash on the superior medial thighs. inciting an inflammatory response which upregulates the immune system to clear the infection [4] . Topical cidofovir has been used in the immunosuppressed population, but has not been systemically studied in the general population [5, 6] . This is the first case report of a broad-spectrum anti-microbial demonstrating efficacy in this common condition. PVP-I is used primarily in dermatology as a surgical preparation as it has been recognized as a broad spectrum, resistance-free biocidal agent for many years. Though incompletely understood, it is likely that free iodine poisons electron transport, inhibits cellular respiration, destabilizes membranes, inhibits protein synthesis and denatures nucleic acids. Although PVP-I kills microorganisms including bacteria, viruses, yeasts, molds, fungi and protozoa, it has scarcely been used for purposes outside of skin asepsis in dermatology [7] .
DMSO is a very effective pharmaceutical vehicle, greatly enhancing percutaneous penetration when used in combination with other substances. DMSO facilitates diffusion through the stratum corneum, triggers the formation of drug deposition in the dermis, and promotes transport into local blood vessels [8] .
Compounded PVP-I in a DMSO vehicle is commonly used in our practice for a variety of indications such as onychomycosis, verruca vulgaris, chemotherapy-associated paronychia, and granulation tissue.
CONCLUSION
We have had remarkable success with this novel combination. The lack of prescription FDA-approved therapies presents both a clinical dilemma for the practitioner and the patient as 
